Company Overview

Update
Founded:
2013
Founders:
Roberto Guerrieri
Headquarters:
Bologna
Funding:
$2.6M
Categories:
Biotechnology
Description:
CellPly advances personalized cancer treatment by providing diagnostic tools for defining the efficacy of immunotherapies and

Detailed Description

Update

CellPly advances personalized cancer treatment by providing diagnostic tools for defining the efficacy of immunotherapies and chemotherapies on cancer and immune cells. CellPly platform analyzes small ex-vivo samples and rare cells immediately after obtaining them from patients and preserving microenvironment conditions to readily provide information about tumor cell sensitivity to drugs and in-vivo status of single immune cells located close to tumor cells. Our solution will help oncologists selecting the best treatment options, scientists studying cell response to therapy, and pharmaceutical companies increasing drug efficacy and rescuing drugs with limited efficacy through patient stratification.

Current Team (2)

Update

Funding Rounds (1) - $2.6M

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    Via Fondazza 53

    Bologna, 40125

    ITA

Images (1)

Update
  • 617ebee8d550c9101e21fa3a88dca24d